Steroids Sold As Supplements Targeted In FDA Actions, Congressional Hearing
This article was originally published in The Tan Sheet
Enhanced FDA enforcement against steroid products sold as dietary supplements is likely reassuring to law-abiding supplement companies
You may also be interested in...
Highlighting dietary supplement sector's self-regulation at a recent supplement industry regulatory conference, the sports nutrition product marketer's chief counsel Bill Carter described his experience in federal court in 2012. He suggested some supplement firms, like Bodybuilding.com previously, don't consider themselves likely to incur litigation or criminal charges linked to regulatory problems when they learn about other businesses that have. "Just because you don't hear about a lot of FDA's office of Criminal Investigations doesn't mean they're not active," he said.
Health Canada warns of benzocaine risk; Perrigo first with store-brand Mucinex; NAD enters Glaxo/Colgate toothpaste war; Sun Capital snags supplement manufacturer CornerStone; more news In Brief.
Bodybuilding.com recalls 65 dietary supplements FDA says are spiked with steroids. The company said in a Nov. 3 release that it is recalling the products due to "an abundance of caution," even though it has not confirmed FDA's concerns or received any adverse event reports for the recalled products. The worldwide recall includes products with the ingredients branded as Superdrol, Madol, Tren, Androstenedine and Turinabol. The recall follows an FDA raid of Bodybuilding.com's facility in Meridian, Idaho, in September (1"The Tan Sheet" Sept. 28, 2009)